Generic placeholder image

Anti-Cancer Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5206
ISSN (Online): 1875-5992

Novel Diaryl or Heterocyclic Sulfonamides as Antimitotic Agents

Author(s): Laixing Hu, Zhuo-rong Li, Jian-dong Jiang and David W. Boykin

Volume 8, Issue 7, 2008

Page: [739 - 745] Pages: 7

DOI: 10.2174/187152008785914806

Price: $65

Abstract

The sulfonamides constitute an important class of drugs, which display a variety of activities including antibacterial, anticarbonic anhydrase, diuretic, hypoglycemic and antithyroid effectiveness. A number of sulfonamides have been reported to be potent anticancer agents, which interact with a wide range of different cellular targets. Among these interesting sulfonamides, the diaryl or heterocyclic sulfonamides have recently emerged as an important class of antimitotic agents against different types of cancer, including multidrug resistant tumors. This review summarizes the recent advances of the diaryl or heterocyclic sulfonamides as novel antimitotic agents.

Keywords: Antimitotic Agents, Heterocyclic Sulfonamides, anticarbonic anhydrase, hypoglycemic, potent anticancer agents, tumor cell, structure-activity relationships (SAR)


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy